Rezlidhia Prices, Coupons, Copay Cards & Patient Assistance
Rezlidhia (olutasidenib) is a member of the miscellaneous antineoplastics drug class and is commonly used for Acute Myeloid Leukemia.
The cost for Rezlidhia 150 mg oral capsule is around $17,468 for a supply of 30 capsules, depending on the pharmacy you visit. Quoted prices are for cash-paying customers and are not valid with insurance plans. This price guide is based on using the Drugs.com discount card which is accepted at most U.S. pharmacies.
Rezlidhia is available as a brand name drug only, a generic version is not yet available. View generic Rezlidhia availability for more details.
Rezlidhia prices
Oral Capsule
150 mg
Rezlidhia oral capsule
from $17,468.24
for 30 capsules
Quantity | Per unit | Price |
---|---|---|
30 | $582.27 | $17,468.24 |
Important: When there is a range of pricing, consumers should normally expect to pay the lower price. However, due to stock shortages and other unknown variables we cannot provide any guarantee.
Rezlidhia Coupons, Copay Cards and Rebates
Rezlidhia offers may take the form of printable coupons, rebates, savings or copay cards, trial offers, or free samples. Certain offers may be printable from a website while others may require registration, completing a questionnaire, or obtaining a sample from a medical professional.
Drugs.com Printable Discount Card
The free Drugs.com Discount Card works like a coupon and can save you up to 80% or more off the cost of prescription medicines, over-the-counter drugs and pet prescriptions.
Print Free Discount CardNote: This is a drug discount program, not an insurance plan. Valid at all major chains including Walgreens, CVS Pharmacy, Target, WalMart Pharmacy, Duane Reade and 65,000 pharmacies nationwide.
Rezlidhia Copay Assistance
Eligible commercially insured patients may pay as little as $15 per prescription with an annual savings of $25,000.
- Applies to:
- Rezlidhia
- Number of uses:
- Per prescription per year
Form more information phone: 833-744-3562 or Visit website
Rezlidhia Free Drug Supply
Eligible commercially insured patient who are experiencing a coverage delay of more than 5 business days may receive up to a 60 day supply of medication and/or insurance coverage determination.
- Applies to:
- Rezlidhia
- Number of uses:
- Temporary Assistance
Form more information phone: 833-744-3562 or Visit website
Patient Assistance & Copay Programs for Rezlidhia
Patient assistance programs (PAPs) are typically sponsored by pharmaceutical companies and offer cost-free or discounted medicines, as well as copay programs, to individuals with low income or those who are uninsured/under-insured and meet specific criteria. Eligibility requirements for each program may vary.
Provider: HealthWell Foundation Copay Program
Eligibility requirements:- May have insurance
- Varies
- FDA Approved Diagnosis - See Program Website for Details
- The patient must also be residing in the US.
- This program provides financial assistance to eligible individuals to cover coinsurance, copayments, healthcare premiums and deductibles for certain treatments. Also, for those who are eligible for health insurance, but cannot afford the insurance premium, the foundation may be able to help by paying some or all of the medical portion of insurance premiums. The patient is being treated for a specific disease for which funding is available and has insurance that covers the treatment for this disease. Call for most recent medications as the list is subject to change.
- Rezlidhia (olutasidenib) Capsule
More information please phone: 800-675-8416 Visit Website
Provider: Patient Access Network Foundation (PAN)
Eligibility requirements:- *See Additional Information section below
- Between 400-500% of FPL
- FDA Approved Diagnosis - See Program Website for Details
- Must reside and receive treatment in US
- *Patients must have health insurance and their insurance must cover the qualifying medication for which they seek assistance.Call for most recent medications as the list is subject to change and the medication for which you are seeking assistance must treat the disease directly. Note: All new enrollment is now done electronically or over the phone. Contact program for details.
- Rezlidhia (olutasidenib) Capsule
More information please phone: 866-316-7263 Visit Website
Provider: Rigel OneCare Program: Rezlidhia
Eligibility requirements:- Contact program for details.
- At or below 500% of FPL
- FDA-approved diagnosis
- Must be a legal resident of the United States or its territories
- Co-payment assistance, reimbursement support, patient support, and patient assistance programs are available for eligible patients.This program may provide a Bridge Program for eligible patients who experience a delay, temporary loss, or change in coverage. Contact program for details.
- Rezlidhia (olutasidenib) Capsule
More information please phone: 833-744-3562 Visit Website
Disclaimer: Medication pricing is sourced from a variety of providers. Pricing may vary significantly due to several factors including brand or generic status, insurance coverage, pharmacy choice, location, and manufacturer pricing policies. Prices are subject to change. For the most accurate and up-to-date information, always consult directly with your pharmacy or healthcare provider.
More about Rezlidhia (olutasidenib)
- Check interactions
- Compare alternatives
- Drug images
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: miscellaneous antineoplastics
- Breastfeeding
- En español